The absorbance difference measured when angiotensinconverting enzyme (EC 3.4.15.1) hydrolyzes the substrate N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine is the basis for measuring its activity. We show this difference to be instrument dependent, and describe a method for deriving it that is applicable to manual or automated procedures. Recently, this method has been adapted for the Multistat ifi centrifugal analyzer (3) and the Olli C Compact Clinical Analyzer (4).
Materials and Methods

Reagents
FAPGG was purchased from Sigma Chemical Co., St. Louis, MO 63178. FAP was a generous gift from S. RoncaTestom (Institute of Biological Chemistry, Faculty of Medicine, University of Pisa, Italy); it can also be purchased from Laboratorio Baldacci, Via S. Michele delgi Scalzi, 56100
Pisa, Italy. Borate buffer, 0.16 moIJL, pH 8.2, containing 0.6 mol of NaC1 per liter.
FAPGG,
2.0 mmoIJL in borate buffer, is stored in a dark bottle at 4#{176}C and is stable for several weeks. 
Measurement of tA
On enzymic hydrolysis, FAPGG forms FAP and glycyiglycine. FAPGG and FAP absorb at 345 nm; glycylglycine does not. A decrease of 1.0 mmol of FAPGG per liter causes an increase of 1.0 mmol/L in FAP, and the change in absorbance measures the net absorbance change due to this decrease in FAPGG and increase in FAP. Because FAPGG absorbs more strongly than FAP, the net absorbance is a negative change.
To simulate an enzyme reaction to deplete 0.1 mmol of FAPGG per liter and form 0.1 mmol of FAP per liter, prepare the following solutions:
(a) Dilute solutions of FAPGG and FAP with the borate buffer to give three concentrations of each: 1.0, 0.9, and 0.8 mmolJL. Measure the absorbance of these six solutions at 345 nm, using matched glass cuvettes of 1-cm lightpath. Use the borate buffer as a blank for the FAP solutions, but use the dichromate blank for the FAPGG solutions because of the high absorbances involved. Plot the measured absorbances of the FAPGG and FAP solutions vs concentration and determine the line of best fit of the slope for each to get the #{163}4 per 0.1 mmoIJL. The difference gives the theoretical net #{163}4.
(b) Alternatively, using 1.0 mmol/L solutions of FAPGG and FAP, prepare mixtures of both solutions in the following proportions: 10 + 0,9 + 1, and 8 + 2, respectively. Thus, the three mixtures contain, per liter, 1.0 mmol of FAPGG, 0.9 mmol of FAPGG and 0.1 mmol of FAP, and 0.8 mmol of FAPGG and 0.2 mmol of FAP. Measure the absorbances of these three mixtures as before vs the dichromate blank and determine #{163}4 per 0.1 mmol/L as before, which in this case is the net #{163}4.
We used the Unicam SP8000 spectrophotometer (Pye Unicain Ltd., Cambridge, U.K.) with the slit width set at 1.0 mm to minimize noise. We also used the Techtron 635 spectrophotometer with 1.0-mm slit width (Varian Techtron Pty. Ltd., Melbourne, Australia) and the Ultrospec 4050 spectrophotometer (LKB-Produkter AB, Bromma, Sweden), which has no slit width adjustments. Interestingly, #{163}4 as measured with the Varian and the LKB spectrophotometers gave results that were different not only for the two methods but also for different spectrophotometers ( Table 1) . As before, #{163}4 was greater for the mixture than the value derived by difference. The differences in #{163}4 values as determined by use of the three spectrophotometers confirm that #{163}4 is instrument dependent.
We compared results by the kinetic method (y) with those obtained by colorimetry (x) (5) for 87 samples. The resulting least-squares linear-regression equation, calculated according to Deming, was y 1.67x + 13, and the correlation coefficient (r) was 0.86. The kinetic ACE assay gave a mean activity of 68 U/L with a 2 SD range of 32-105 U/L for samples from 54 blood donors. This reference interval for normal subjects is lower than those previously reported (2-4) because of the higher #{163}4 used in calculating the enzyme activity. Like R#{248}mer (6), we have not observed any significant sex-related differences in reference interval, although this has been reported by others.
The within-day precision (CV) of the kinetic method was 3.9 and 4.0% for normal and above-normal ACE activity in serum for respective activities (mean ± SD) of 72 ± 2.8 and 116 ± 4.7 U/L (n = 12 each). For between-day precision, the CVs were 3.0 and 3.5%, respectively, for ACE activities of 85 ± 2.6 and 141 ± 4.9 U/L (n = 12 each).
The kinetic assay we outline is essentially a modification of Ronca-Testoni's method (2), to use standard cuvettes with a 1-cm lightpath. We consider this kinetic ACE method to be the easiest and most convenient method available for the clinical laboratory. The method is also ideal for measuring the low ACE activity in bronchoalveolar lavage fluid, where a larger sample volume, e.g., 1.2 mL, may be used in the assay method and the water omitted.
The scheme we propose allows #{163}4 to be easily and accurately measured on manual and automated systems.
The finding that #{163}4 is instrument dependent is consistent with the different #{163}4 values previously reported (2) (3) (4) , although the importance of this observation has not been previously appreciated. Unless #{163}4 is accurately established, the kinetic measurement of ACE activity may not be reliable.
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